About

Richmond CDMO fully-integrated biotech services from development to supply chain. Single-use upstream and downstream GMP processing Mammalian cell culture platform for recombinant proteins and adenoviruses Fully automated filling and packaging lines for vials, pfs and cartridges. About Laboratorios Richmond SACIF We are a regional pharmaceutical company and CDMO based in Argentina that develops and produces medicines using cutting-edge technology. Our portfolio includes generic products, biosimilars, and technology licenses and transfers from key countries. We also create innovative solutions by combining different active ingredients in a single tablet and developing user-friendly packaging that facilitates therapeutic adherence and significantly improves our patients' quality of life. Biotechnology Plant: A unit dedicated to the production of 100% of the production cycle for both ​vaccines and complex biotechnological products.​ As CDMO we offer our development and production capacity for biologicals, including vaccines and biosimilars.​ ​The plant has over 10,000 m2 dedicated to the production of ​b​iological active ingredients and finished products, ​it​ includes a GMP-compliant pilot plant and QC laboratories. The plant is equipped with single-use technology​ (upto 1000-L bioprocess) and ​h​as completely independent ​F&F areas distributed across two lines, providing maximum flexibility. The total estimated capacity will be approximately 80 million vials and 28 million syringes per year​.